Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein

doi:10.1084/jem.156.1.230

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by de Beer, F. C.
	Articles by Pepys, M. B.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by de Beer, F. C.
	Articles by Pepys, M. B.


Social Bookmarking

	What's this?

ARTICLES

Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein

FC de Beer, AK Soutar, ML Baltz, IM Trayner, A Feinstein and MB Pepys

C-reactive protein (CRP), the classical acute-phase protein, can bind phospholipids by virtue of its specific, calcium-dependent reactivity with phosphorylcholine residues. However, analysis of acute-phase serum by gel filtration and by density gradient ultracentrifugation showed that the CRP was in a free, uncomplexed form, despite the coexistent presence of the various classes of serum lipoproteins, all of which contain phospholipids. In contrast, when isolated CRP was aggregated by immobilization at a sufficient density on a solid phase and then exposed to normal human serum, it selectively bound low density lipoprotein (LDL) and traces of very low density lipoprotein. The reaction was calcium dependent and reversible by free phosphorylcholine but not by heparin. LDL isolated from normal plasma was also bound by aggregated CRP. CRP reacts in vitro with a wide variety of different ligands both of extrinsic and of autogenous origin, e.g., microbial products and damaged cell membranes, respectively. If CRP aggregated in vivo by complexing with these ligands than acquires the capacity to selectively bind LDL, the phenomenon may have significant implications for the function of CRP and for the metabolism, clearance, and deposition of LDL.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Singh, S. K., Suresh, M. V., Prayther, D. C., Moorman, J. P., Rusinol, A. E., Agrawal, A. (2008). C-Reactive Protein-Bound Enzymatically Modified Low-Density Lipoprotein Does Not Transform Macrophages into Foam Cells. J. Immunol. 180: 4316-4322 [Abstract] [Full Text]
Marsik, C., Kazemi-Shirazi, L., Schickbauer, T., Winkler, S., Joukhadar, C., Wagner, O. F., Endler, G. (2008). C-Reactive Protein and All-Cause Mortality in a Large Hospital-Based Cohort. Clin. Chem. 54: 343-349 [Abstract] [Full Text]
Kovacs, A., Tornvall, P., Nilsson, R., Tegner, J., Hamsten, A., Bjorkegren, J. (2007). Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemia. Proc. Natl. Acad. Sci. USA 104: 13768-13773 [Abstract] [Full Text]
Jenny, N. S., Arnold, A. M., Kuller, L. H., Tracy, R. P., Psaty, B. M. (2007). Serum Amyloid P and Cardiovascular Disease in Older Men and Women: Results from the Cardiovascular Health Study. Arterioscler. Thromb. Vasc. Bio. 27: 352-358 [Abstract] [Full Text]
Pepys, M. B., Hawkins, P. N., Kahan, M. C., Tennent, G. A., Gallimore, J. R., Graham, D., Sabin, C. A., Zychlinsky, A., de Diego, J. (2005). Proinflammatory Effects of Bacterial Recombinant Human C-Reactive Protein Are Caused by Contamination With Bacterial Products, Not by C-Reactive Protein Itself. Circ. Res. 97: e97-e103 [Abstract] [Full Text]
Torzewski, J. (2005). C-Reactive Protein and Atherogenesis: New Insights from Established Animal Models. Am. J. Pathol. 167: 923-925 [Full Text]
Hirschfield, G. M., Gallimore, J. R., Kahan, M. C., Hutchinson, W. L., Sabin, C. A., Benson, G. M., Dhillon, A. P., Tennent, G. A., Pepys, M. B. (2005). Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice. Proc. Natl. Acad. Sci. USA 102: 8309-8314 [Abstract] [Full Text]
Pepys, M. B. (2005). CRP or not CRP? That Is the Question. Arterioscler. Thromb. Vasc. Bio. 25: 1091-1094 [Full Text]
Hilpert, K. F., Kris-Etherton, P. M., West, S. G. (2005). Lipid Response to a Low-Fat Diet with or without Soy Is Modified by C-Reactive Protein Status in Moderately Hypercholesterolemic Adults. J. Nutr. 135: 1075-1079 [Abstract] [Full Text]
van Tits, L., de Graaf, J., Toenhake, H., van Heerde, W., Stalenhoef, A. (2005). C-Reactive Protein and Annexin A5 Bind to Distinct Sites of Negatively Charged Phospholipids Present in Oxidized Low-Density Lipoprotein. Arterioscler. Thromb. Vasc. Bio. 25: 717-722 [Abstract] [Full Text]
Manolov, D. E., Rocker, C., Hombach, V., Nienhaus, G. U., Torzewski, J. (2004). Ultrasensitive Confocal Fluorescence Microscopy of C-Reactive Protein Interacting With Fc{gamma}RIIa. Arterioscler. Thromb. Vasc. Bio. 24: 2372-2377 [Abstract] [Full Text]
Khovidhunkit, W., Kim, M.-S., Memon, R. A., Shigenaga, J. K., Moser, A. H., Feingold, K. R., Grunfeld, C. (2004). Thematic review series: The Pathogenesis of Atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the host. J. Lipid Res. 45: 1169-1196 [Abstract] [Full Text]
Hirschfield, G.M., Pepys, M.B. (2003). C-reactive protein and cardiovascular disease: new insights from an old molecule. QJM 96: 793-807 [Abstract] [Full Text]
Brull, D.J., Serrano, N., Zito, F., Jones, L., Montgomery, H.E., Rumley, A., Sharma, P., Lowe, G.D.O., World, M.J., Humphries, S.E., Hingorani, A.D. (2003). Human CRP Gene Polymorphism Influences CRP Levels: Implications for the Prediction and Pathogenesis of Coronary Heart Disease. Arterioscler. Thromb. Vasc. Bio. 23: 2063-2069 [Abstract] [Full Text]
Hazen, S. L., Chisolm, G. M. (2002). Oxidized phosphatidylcholines: Pattern recognition ligands for multiple pathways of the innate immune response. Proc. Natl. Acad. Sci. USA 99: 12515-12517 [Full Text]
Winbeck, K., Poppert, H., Etgen, T., Conrad, B., Sander, D. (2002). Prognostic Relevance of Early Serial C-Reactive Protein Measurements After First Ischemic Stroke. Stroke 33: 2459-2464 [Abstract] [Full Text]
Zwaka, T. P., Hombach, V., Torzewski, J. (2001). C-Reactive Protein-Mediated Low Density Lipoprotein Uptake by Macrophages : Implications for Atherosclerosis. Circulation 103: 1194-1197 [Abstract] [Full Text]
Noursadeghi, M., Bickerstaff, M. C. M., Gallimore, J. R., Herbert, J., Cohen, J., Pepys, M. B. (2000). Role of serum amyloid P component in bacterial infection: Protection of the host or protection of the pathogen. Proc. Natl. Acad. Sci. USA 97: 14584-14589 [Abstract] [Full Text]
Danesh, J., Whincup, P., Walker, M., Lennon, L., Thomson, A., Appleby, P., Gallimore, J R., Pepys, M. B (2000). Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 321: 199-204 [Abstract] [Full Text]
Bhakdi, S., Torzewski, M., Klouche, M., Hemmes, M. (1999). Complement and Atherogenesis : Binding of CRP to Degraded, Nonoxidized LDL Enhances Complement Activation. Arterioscler. Thromb. Vasc. Bio. 19: 2348-2354 [Abstract] [Full Text]
Grunfeld, C., Marshall, M., Shigenaga, J. K., Moser, A. H., Tobias, P., Feingold, K. R. (1999). Lipoproteins inhibit macrophage activation by lipoteichoic acid. J. Lipid Res. 40: 245-252 [Abstract] [Full Text]
Torzewski, J., Torzewski, M., Bowyer, D. E., Frohlich, M., Koenig, W., Waltenberger, J., Fitzsimmons, C., Hombach, V. (1998). C-Reactive Protein Frequently Colocalizes With the Terminal Complement Complex in the Intima of Early Atherosclerotic Lesions of Human Coronary Arteries. Arterioscler. Thromb. Vasc. Bio. 18: 1386-1392 [Abstract] [Full Text]